Only a small percentage of the population had these adverse effects for AstraZeneca, Health Undersecretary Maria Rosario said
The Philippines will resume administering AstraZeneca’s COVID-19 vaccine to people below 60 years of age, health officials said on Monday, ending a temporary suspension over reports of rare blood clots in younger recipients overseas,
“The benefit outweighs the risk. Only a small percentage of the population had these adverse effects for AstraZeneca,” Health Undersecretary Maria Rosario Vergeire told a regular news conference, referring to the countries where blood clots were reported.
Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.
Comments
0 comment